Enkam, Forenap Pharma EURL, Lundbeck, Qualissima S.a.r.l neurology news

Enkam and partners Lundbeck, Forenap and Qualissima received €6 million ($8 million) from the EU's seventh Framework Program (FP7) to develop Enkam's FGLs to treat Alzheimer's disease. The fibroblas...